edwards lifesciences (nyse: ew) is a global leader in products and technologies to treat advanced cardiovascular disease, the global leader in acute hemodynamic monitoring and the number-one heart valve company in the world.  headquartered in irvine, california, edwards has more than 5,600 employees worldwide, selling medical technologies in nearly 100 countries with 2007 sales of $1.091 billion.  eighty-five percent of the company’s sales come from brands with leading global market positions, including carpentier-edwards, cosgrove-edwards, fogarty, perimount and swan-ganz.<br><br>edwards lifesciences leverages its research, design, development and marketing expertise to produce products that address specific cardiovascular opportunities including heart valve disease, vascular disease and critical care technologies.    <br><br>2007 sales:  $1.091 billion <br><br>employees:  more than 5,600 worldwide <br><br>top company official:  michael a. mussallem, chairman and ceo <br><br>corporate headquarters: usa -  irvine, ca<br><br>edwards irvine headquarters is home to the world’s most advanced heart valve therapy manufacturing plant and the museum of heart valve design, the most prominent facility of its kind in the world. the clinicians, inventors, research and devices showcased in the museum span the history of heart valve therapies, from the first devices to today’s most sophisticated technologies. <br><br>manufacturing facilities:<br>irvine, ca <br>midvale, ut  <br>dominican republic - haina, san cristobal <br>switzerland - horw <br>puerto rico - anasco<br>singapore - techview